\n\n\n\n It is critical to note, however, that preclinical safety data no matter how consistently positive cannot be directly extrapolated to humans without proper clinical trials
Some people find that it takes a while before symptoms start to improve and disappear
Reported benefits (per available research): Studied for its ability to produce sustained, dose-dependent increases in growth hormone and IGF-1 secretion in a Phase 1 human trial in healthy adults, published by Teichman et al
I look at both the blood volume and a blood B12 level on our Comprehensive Blood Analysis test here 2
These effects were abrogated in skeletal muscle-specific ERR knockout models, confirming the compounds mechanism of action via ERR (Billon et al
Preclinical adipocyte research has investigated HGH Fragment 176-191 for its capacity to upregulate beta-3 adrenergic receptor-mediated lipolysis and inhibit fatty acid uptake via lipogenesis pathway suppression independent of systemic GH effects